Endoscopic, Image-Guided, Transnasal Instillation of ³²P for Recurrent Infrachiasmatic Cystic Craniopharyngioma

Abstract

Introduction: The neurovascular and anatomic relationships surrounding craniopharyngiomas, and their tending to recur despite any method of primary treatment, has characterized this tumor as an exigent and frustrating clinical entity. Various strategies have been developed to deal with recurrences which include radical re-resection, stereotactic or localized radiotherapy, cyst fenestration, marsupialization or stent placement, and intracavitary therapies such as bleomycin or radionucleotides.

Case Report: We present a case where the patient had previously experienced a transsphenoidal resection followed by a pterional, microsurgical resection of her craniopharyngioma at an outside hospital. The second recurrence was cystic, and confined to the sella. We elected to proceed with a minimally invasive, transnasal endoscopic approach for the instillation of phosphorus 32 radionucleotide into the cyst. There were no complications, and the patient was discharged home on postoperative day one. At six months, there was no progression of the cyst.

Conclusion: While intracystic adionucleotide therapies have been utilized for primary and secondary treatment of craniopharyngioma, to our knowledge, this is the first report of the delivery of this therapy by an endoscopic transsphenoidal route.

References

• 1 Wang KC. et al . Origin of craniopharyngiomas: implication on the growth pattern.  Childs Nerv Syst. 2005;  21 628-634
• 2 Prabhu VC, Brown HG. The pathogenesis of craniopharyngiomas.  Childs Nerv Syst. 2005;  21 622-627
• 3 Tew J, van Loveren H, Keller J. AtlasoOf Operative Microneurosurgery: Vol. 2 BrainTumors. 1st edn., R. Zorab (Ed.) Philadelphia, W.B. Saunders Company 2001: p 114
• 4 Merchant TE. et al . Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function.  J Neurosurg. 2006;  104 ((2 Suppl)) 94-102
• 5 Boop FA. Craniopharyngioma.  J Neurosurg. 2007;  106 ((1 Suppl)) 1-2 , ; discussion 2.
• 6 Puget S. et al . Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement.  J Neurosurg. 2007;  106 ((1 Suppl)) 3-12
• 7 DiPatri  Jr  AJ, Prabhu V. A history of the treatment of craniopharyngiomas.  Childs Nerv Syst. 2005;  21 606-621
• 8 Tomita T, Bowman RM. Craniopharyngiomas in children: surgical experience at Children's Memorial Hospital.  Childs Nerv Syst. 2005;  21 729-746
• 9 Zuccaro G. Radical resection of craniopharyngioma.  Childs Nerv Syst. 2005;  21 679-690
• 10 Albright AL. et al . Individualized treatment of pediatric craniopharyngiomas.  Childs Nerv Syst. 2005;  21 649-654
• 11 Caldarelli M. et al . Management of recurrent craniopharyngioma.  Acta Neurochir (Wien). 1998;  140 447-454
• 12 Minamida Y. et al . Surgical management of the recurrence and regrowth of craniopharyngiomas.  J Neurosurg. 2005;  103 224-232
• 13 Laws  Jr  ER, Vance ML. Radiosurgery for pituitary tumors and craniopharyngiomas.  Neurosurg Clin N Am. 1999;  10 327-336
• 14 Chiou SM. et al . Stereotactic radiosurgery of residual or recurrent craniopharyngioma, after surgery, with or without radiation therapy.  Neuro-oncol. 2001;  3 159-166
• 15 Pollock BE, Natt N, Schomberg PJ. Stereotactic management of craniopharyngiomas.  Stereotact Funct Neurosurg. 2002;  79 25-32
• 16 Kalapurakal JA. Radiation therapy in the management of pediatric craniopharyngiomas – a review.  Childs Nerv Syst. 2005;  21 808-816
• 17 Caceres A. Intracavitary therapeutic options in the management of cystic craniopharyngioma.  Childs Nerv Syst. 2005;  21 705-718
• 18 Taasan V. et al . Phosphorus-32 therapy of cystic grade IV astrocytomas: technique and preliminary application.  J Nucl Med. 1985;  26 1335-1338
• 19 Rudnick EF, DiNardo LJ. Image-guided endoscopic endonasal resection of a recurrent craniopharyngioma.  Am J Otolaryngol. 2006;  27 266-267
• 20 Locatelli D. et al . Endoscopic approach for the treatment of relapses in cystic craniopharyngiomas.  Childs Nerv Syst. 2004;  20 ((11–12)) p.863-867
• 21 Teo C. Application of endoscopy to the surgical management of craniopharyngiomas.  Childs Nerv Syst. 2005;  21 696-700
• 22 Kadri H, Mawla AA. Endoscopy-assisted microsurgical total resection of craniopharyngioma in childhood.  Minim Invas Neurosurg. 2006;  49 369-372
• 23 Delitala A, Brunori A, Chiappetta F. Purely neuroendoscopic transventricular management of cystic craniopharyngiomas.  Childs Nerv Syst. 2004;  20 858-862
• 24 Nicolato A. et al . Multimodality stereotactic approach to the treatment of cystic craniopharyngiomas.  Minim Invas Neurosurg. 2004;  47 32-40
• 25 Backlund EO. et al . Treatment of craniopharyngiomas – the stereotactic approach in a ten to twenty-three years’ perspective. I. Surgical, radiological and ophthalmological aspects.  Acta Neurochir (Wien). 1989;  99 11-19
• 26 Hasegawa T. et al . Management of cystic craniopharyngiomas with phosphorus-32 intracavitary irradiation.  Neurosurgery. 2004;  54 813-820 , ; discussion 820–822.
• 27 Pollock BE. et al . Phosphorus-32 intracavitary irradiation of cystic craniopharyngiomas: current technique and long-term results.  Int J Radiat Oncol Biol Phys. 1995;  33 437-446
• 28 Hechtman CD. et al . Dose distribution outside of a sphere of P-32 chromic phosphorous colloid.  Int J Radiat Oncol Biol Phys. 2005;  63 961-968
• 29 Sadeghi M. et al . Dosimetry of (32)P radiocolloid for treatment of cystic craniopharyngioma.  Appl Radiat Isot. 2007;  65 519-523

Correspondence